IP Library › Assignment 075109/0434

Patent Assignment

Reel/Frame 075109/0434

Release of Security Interest

Recorded: 2026-03-12 Pages: 14

View PDF Order Certified Copy

Assignor

TMF GROUP NEW YORK, LLC, NOT INDIVIDUALLY BUT SOLELY AS COLLATERAL AGENT

Executed: 2026-03-12

Assignee

BIOSPLICE THERAPEUTICS, INC.

6555 NANCY RIDGE DRIVE, SUITE 300, SAN DIEGO, CALIFORNIA, 92121

Covered Properties (119)

ß- AND Y -DIKETONES AND Y -HYDROXYKETONES AS WNT/ ß -CATENIN SIGNALING PATHWAY ACTIVATORS

Application: 17/113,895 →

Publication: US 2021/0353604

Methods of Treating Cancer Using a Clk Inhibitor

Application: 17/254,352 →

Publication: US 2022/0062240

Methods of Treating Cartilage Disorders Through Inhibition of Clk and Dyrk

Application: 17/423,761 →

Publication: US 2023/0000842

1H-Pyrrolo[2,3-B]Pyridines and Preparation and Uses Thereof

Application: 17/964,423 →

Publication: US 2023/0192686

Substituted Pyrrolo[2,3-D]Pyrimidines as DYRK1A Inhibitors

Application: 17/964,470 →

Publication: US 2023/0167133

Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof

Application: 18/315,047 →

Publication: US 2024/0116927

4-Alkoxypyrrolo[2,1-F][1,2,4]Triazines and Preparation and Uses Thereof

Application: 18/340,543 →

Publication: US 2024/0002391

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 8,450,340 →

Application: 12/968,505 →

Publication: US 2011/0190290

Beta- and Gamma-Diketones and Gamma-Hydroxyketones as Wnt/Beta-Catenin Signaling Pathway Activators

Patent: 8,609,717 →

Application: 13/211,665 →

Publication: US 2012/0046320

Indazole-3-Carboxamides and Their Use as Wnt/Beta-Catenin Signaling Pathway Inhibitors

Patent: 9,221,793 →

Application: 13/614,296 →

Publication: US 2013/0079329

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 8,815,897 →

Application: 13/855,874 →

Publication: US 2013/0225576

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 8,883,822 →

Application: 13/887,177 →

Publication: US 2013/0296302

Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof

Patent: 8,604,052 →

Application: 13/938,691 →

Publication: US 2013/0296341

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 8,846,714 →

Application: 13/938,692 →

Publication: US 2013/0296307

B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators

Patent: 8,629,176 →

Application: 14/019,092 →

Publication: US 2014/0005228

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 8,618,128 →

Application: 14/019,147 →

Publication: US 2014/0005383

Indazole-3-Carboxamides and Their Use as Wnt/Beta-Catenin Signaling Pathway Inhibitors

Patent: 8,697,887 →

Application: 14/019,229 →

Publication: US 2014/0045815

B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators

Patent: 8,921,413 →

Application: 14/086,529 →

Publication: US 2014/0080902

3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signaling Pathway and Therapeutic Uses Thereof

Patent: 9,908,867 →

Application: 14/149,948 →

Publication: US 2014/0194441

Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators

Patent: 9,533,976 →

Application: 14/187,063 →

Publication: US 2014/0243349

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 8,901,150 →

Application: 14/331,427 →

Publication: US 2014/0323479

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 9,012,472 →

Application: 14/454,279 →

Publication: US 2015/0072981

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 9,067,939 →

Application: 14/465,056 →

Publication: US 2015/0045360

B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators

Patent: 9,303,010 →

Application: 14/547,858 →

Publication: US 2015/0299174

B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators

Patent: 9,493,437 →

Application: 14/547,951 →

Publication: US 2015/0299157

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 9,233,104 →

Application: 14/621,222 →

Publication: US 2015/0150862

5-Substituted Indazole-3-Carboxamides and Preparation and Use Thereof

Patent: 9,745,271 →

Application: 14/664,517 →

Publication: US 2015/0266825

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 9,446,035 →

Application: 14/718,354 →

Publication: US 2016/0101092

Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof

Patent: 9,381,192 →

Application: 14/741,645 →

Publication: US 2016/0128991

Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles

Patent: 9,795,550 →

Application: 14/831,456 →

Publication: US 2016/0206540

2-(1H-Indazol-3-Yl)-1H-Imidazo[4,5-C]Pyridine and Therapeutic Uses Thereof

Patent: 9,475,807 →

Application: 14/847,259 →

Publication: US 2016/0075701

3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 9,540,398 →

Application: 14/847,287 →

Publication: US 2016/0068547

3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 9,657,016 →

Application: 14/847,299 →

Publication: US 2016/0068529

2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-B]Pyridine and Therapeutic Uses Thereof

Patent: 9,738,638 →

Application: 14/847,336 →

Publication: US 2016/0090380

3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 9,475,825 →

Application: 14/847,344 →

Publication: US 2016/0068548

3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof

Patent: 9,493,487 →

Application: 14/847,371 →

Publication: US 2016/0068549

3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof

Patent: 9,758,531 →

Application: 14/847,379 →

Publication: US 2016/0068550

3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 9,546,185 →

Application: 14/847,394 →

Publication: US 2016/0068551

Indazole-3-Carboxamides and Their Use as Wnt/Beta-Catenin Signaling Pathway Inhibitors

Patent: 9,802,916 →

Application: 14/940,958 →

Publication: US 2016/0304488

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 9,586,977 →

Application: 14/962,681 →

Publication: US 2016/0318954

Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof

Patent: 9,763,927 →

Application: 15/184,553 →

Publication: US 2017/0065574

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 9,855,272 →

Application: 15/244,687 →

Publication: US 2017/0202846

3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 9,763,951 →

Application: 15/257,398 →

Publication: US 2017/0216299

3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof

Patent: 9,889,140 →

Application: 15/267,939 →

Publication: US 2017/0224697

2-(1H-Indazol-3-Yl)-1H-Imidazo[4,5-C]Pyridine and Therapeutic Uses Thereof

Patent: 9,828,372 →

Application: 15/298,346 →

Publication: US 2017/0260179

B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators

Patent: 9,884,053 →

Application: 15/349,118 →

Publication: US 2017/0246154

Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators

Patent: 9,951,053 →

Application: 15/356,903 →

Publication: US 2017/0260176

3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 9,815,854 →

Application: 15/357,494 →

Publication: US 2017/0260209

3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 9,844,536 →

Application: 15/363,086 →

Publication: US 2017/0267697

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,071,086 →

Application: 15/420,398 →

Publication: US 2017/0333409

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 10,508,099 →

Application: 15/498,990 →

Publication: US 2017/0313681

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 10,106,527 →

Application: 15/499,013 →

Publication: US 2017/0313682

3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 10,202,377 →

Application: 15/591,566 →

Publication: US 2018/0086754

5-Substituted Indazole-3-Carboxamides and Preparation and Use Thereof

Patent: 10,669,240 →

Application: 15/653,747 →

Publication: US 2018/0127377

2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-B]Pyridine and Therapeutic Uses Thereof

Patent: 10,023,572 →

Application: 15/661,231 →

Publication: US 2018/0148444

3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof

Patent: 10,131,677 →

Application: 15/668,992 →

Publication: US 2018/0141963

3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 10,052,331 →

Application: 15/673,834 →

Publication: US 2018/0177787

Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof

Patent: 10,016,406 →

Application: 15/681,035 →

Publication: US 2018/0153873

Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles

Patent: 10,434,052 →

Application: 15/706,908 →

Publication: US 2018/0193244

Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors

Patent: 10,464,924 →

Application: 15/709,057 →

Publication: US 2018/0237416

2-(1H-Indazol-3-Yl)-1H-Imidazo[4,5-C]Pyridine and Therapeutic Uses Thereof

Patent: 10,081,631 →

Application: 15/716,803 →

Publication: US 2018/0215753

3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 10,533,020 →

Application: 15/716,894 →

Publication: US 2018/0201624

3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof

Patent: 10,463,651 →

Application: 15/749,586 →

Publication: US 2018/0221350

3-(1H-Indol-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof

Patent: 10,604,512 →

Application: 15/749,587 →

Publication: US 2018/0222891

3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof

Patent: 10,350,199 →

Application: 15/749,606 →

Publication: US 2018/0207141

3-(1H-Indol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof

Patent: 10,166,218 →

Application: 15/749,608 →

Publication: US 2018/0228781

3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof

Patent: 10,206,908 →

Application: 15/749,701 →

Publication: US 2018/0214427

3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof

Patent: 10,383,861 →

Application: 15/749,706 →

Publication: US 2018/0221351

3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof

Patent: 10,285,982 →

Application: 15/749,713 →

Publication: US 2018/0228782

3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,226,448 →

Application: 15/749,721 →

Publication: US 2018/0221341

3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B] Pyridines and Therapeutic Uses Thereof

Patent: 10,285,983 →

Application: 15/749,727 →

Publication: US 2018/0228783

3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,231,956 →

Application: 15/749,737 →

Publication: US 2018/0214429

3-(1H-Indol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,226,453 →

Application: 15/749,739 →

Publication: US 2018/0228784

3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,519,169 →

Application: 15/749,742 →

Publication: US 2018/0370989

3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,206,909 →

Application: 15/749,868 →

Publication: US 2018/0228785

3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,195,185 →

Application: 15/749,910 →

Publication: US 2018/0221353

3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B] Pyridines and Therapeutic Uses Thereof

Patent: 10,329,309 →

Application: 15/749,922 →

Publication: US 2018/0222923

3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,188,634 →

Application: 15/749,923 →

Publication: US 2018/0221354

3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,392,383 →

Application: 15/749,929 →

Publication: US 2018/0230142

Methods of Using Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors

Patent: 10,806,726 →

Application: 15/790,544 →

Publication: US 2018/0185343

3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof

Patent: 10,596,154 →

Application: 15/808,602 →

Publication: US 2018/0250269

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,105,370 →

Application: 15/812,629 →

Publication: US 2018/0256588

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 9,951,048 →

Application: 15/833,917 →

Publication: US 2018/0093970

3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof

Patent: 10,206,929 →

Application: 15/843,818 →

Publication: US 2018/0325910

B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators

Patent: 10,314,832 →

Application: 15/855,463 →

Publication: US 2018/0333400

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 10,100,038 →

Application: 15/884,112 →

Publication: US 2018/0155323

3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signaling Pathway and Therapeutic Uses Thereof

Patent: 10,183,929 →

Application: 15/889,403 →

Publication: US 2018/0162840

Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators

Patent: 10,457,672 →

Application: 15/918,086 →

Publication: US 2019/0055227

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 10,287,267 →

Application: 15/925,157 →

Publication: US 2018/0208580

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 10,556,885 →

Application: 15/943,864 →

Publication: US 2018/0222887

2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-B]Pyridine and Therapeutic Uses Thereof

Patent: 10,280,166 →

Application: 16/015,996 →

Publication: US 2019/0055238

1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof

Patent: 10,342,788 →

Application: 16/032,905 →

Publication: US 2019/0134013

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 10,544,128 →

Application: 16/130,842 →

Publication: US 2019/0233396

3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof

Patent: 10,526,347 →

Application: 16/162,155 →

Publication: US 2019/0119303

6-(5-Membered Heteroaryl)Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 10,604,514 →

Application: 16/164,447 →

Publication: US 2019/0119263

6-(6-Membered Heteroaryl & Aryl)Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 10,653,688 →

Application: 16/172,553 →

Publication: US 2019/0125740

6-(5-Membered Heteroaryl)Isoquinolin-3-Yl-(5-Membered Heteroaryl) Carboxamides and Preparation and Use Thereof

Patent: 10,413,537 →

Application: 16/172,589 →

Publication: US 2019/0125741

Diazanaphthalen-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 10,703,748 →

Application: 16/177,149 →

Publication: US 2019/0127370

3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signaling Pathway and Therapeutic Uses Thereof

Patent: 10,654,832 →

Application: 16/252,055 →

Publication: US 2019/0352279

5-Heteroaryl Substituted Indazole-3-Carboxamides and Preparation and Use Thereof

Patent: 10,934,297 →

Application: 16/283,366 →

Publication: US 2019/0263821

Indazole Containing Macrocycles and Therapeutic Uses Thereof

Patent: 10,759,799 →

Application: 16/440,284 →

Publication: US 2019/0382402

Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof

Patent: 10,947,228 →

Application: 16/518,337 →

Publication: US 2020/0190082

6-(5-Membered Heteroaryl)Isoquinolin-3-Yl-(5-Membered Heteroaryl) Carboxamides and Preparation and Use Thereof

Patent: 10,744,128 →

Application: 16/528,023 →

Publication: US 2020/0155540

Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles

Patent: 11,077,046 →

Application: 16/534,455 →

Publication: US 2020/0222295

Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors

Patent: 11,066,388 →

Application: 16/576,308 →

Publication: US 2020/0239436

Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators

Patent: 11,034,682 →

Application: 16/577,592 →

Publication: US 2020/0223834

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 10,947,217 →

Application: 16/703,321 →

Publication: US 2020/0299263

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 11,174,244 →

Application: 16/727,053 →

Publication: US 2020/0339536

Methods of Using Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors

Patent: 11,684,615 →

Application: 16/915,316 →

Publication: US 2021/0121448

5-Heteroaryl Substituted Indazole-3-Carboxamides and Preparation and Use Thereof

Patent: 11,713,320 →

Application: 17/138,098 →

Publication: US 2022/0402921

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 11,548,872 →

Application: 17/155,577 →

Publication: US 2022/0332698

Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof

Patent: 11,697,649 →

Application: 17/168,747 →

Publication: US 2023/0013144

Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators

Patent: 11,673,885 →

Application: 17/241,662 →

Publication: US 2023/0053726

Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors

Patent: 11,780,823 →

Application: 17/346,808 →

Publication: US 2023/0047396

Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles

Patent: 11,839,679 →

Application: 17/362,177 →

Publication: US 2022/0087917

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 11,673,881 →

Application: 17/495,281 →

Publication: US 2023/0104155

Pyrrolo[2,1-F][1,2,4]Triazines and Preparation and Uses Thereof

Patent: 12,134,625 →

Application: 17/964,489 →

Publication: US 2023/0312605

Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof

Patent: 12,281,097 →

Application: 17/990,133 →

Publication: US 2023/0286945

Pyrrolo[2,1-F][1,2,4]Triazines and Preparation and Uses Thereof

PCT: PCT/US2024/023387 ↗

Related Assignments (25)

Other recorded transfers of the patents in this record — the chain of ownership.

Assignment of Assignor's Interest Apr 13, 2011

From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK

To: EPITHERIX, LLC

Reel/Frame 026115/0438 →

Assignment of Assignor's Interest Oct 10, 2011

From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.

To: WINTHERIX LLC

Reel/Frame 027036/0295 →

Merger Jun 26, 2012

From: WINTHERIX, LLC

To: SAMUMED, LLC

Reel/Frame 028442/0313 →

Assignment of Assignor's Interest Jun 26, 2012

From: EPITHERIX, LLC

To: SAMUMED, LLC

Reel/Frame 028442/0355 →

Assignment of Assignor's Interest Dec 10, 2012

From: HOOD, JOHN; KUMAR KC, SUNIL

To: SAMUMED, LLC

Reel/Frame 029436/0421 →

Assignment of Assignor's Interest Jun 21, 2013

From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK

To: SAMUMED, LLC

Reel/Frame 030662/0508 →

Assignment of Assignor's Interest Jul 2, 2013

From: EPITHERIX, LLC

To: SAMUMED, LLC

Reel/Frame 030724/0797 →

Assignment of Assignor's Interest Jul 2, 2013

From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK

To: EPITHERIX, LLC

Reel/Frame 030724/0774 →

Assignment of Assignor's Interest Aug 6, 2013

From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR

To: SAMUMED, LLC

Reel/Frame 030947/0392 →

Assignment of Assignor's Interest Aug 6, 2013

From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK

To: EPITHERIX, LLC

Reel/Frame 030946/0566 →

Assignment of Assignor's Interest Aug 6, 2013

From: EPITHERIX, LLC

To: SAMUMED, LLC

Reel/Frame 030946/0591 →

Merger Oct 11, 2013

From: WINTHERIX, LLC

To: SAMUMED, LLC

Reel/Frame 031389/0977 →

Assignment of Assignor's Interest Oct 11, 2013

From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.

To: WINTHERIX LLC

Reel/Frame 031389/0916 →

Assignment of Assignor's Interest Oct 11, 2013

From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK

To: SAMUMED, LLC

Reel/Frame 031387/0729 →

Assignment of Assignor's Interest Oct 15, 2013

From: HOOD, JOHN; KC, SUNIL KUMAR

To: SAMUMED, LLC

Reel/Frame 031403/0427 →

Assignment of Assignor's Interest Dec 13, 2013

From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.

To: SAMUMED, LLC

Reel/Frame 031780/0868 →

Assignment of Assignor's Interest Feb 12, 2014

From: KC, SUNIL KUMAR; HOOD, JOHN

To: SAMUMED, LLC

Reel/Frame 032200/0146 →

Assignment of Assignor's Interest Jul 8, 2015

From: KC, SUNIL KUMAR; HOOD, JOHN

To: SAMUMED, LLC

Reel/Frame 036025/0001 →

Change of Name Dec 8, 2020

From: WINTHERIX LLC

To: SAMUMED, LLC

Reel/Frame 054581/0436 →

Assignment of Assignor's Interest Dec 8, 2020

From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.

To: WINTHERIX LLC

Reel/Frame 054581/0367 →

Assignment of Assignor's Interest Dec 21, 2020

From: TAM, BETTY; BOSSARD, CARINE; CHIU, KEVIN TSENG; CHUNG, HEEKYUNG

To: SAMUMED, LLC

Reel/Frame 054710/0341 →

Assignment of Assignor's Interest Mar 23, 2021

From: SAMUMED, LLC

To: BIOSPLICE THERAPEUTICS, INC.

Reel/Frame 055694/0001 →

Assignment of Assignor's Interest Mar 23, 2021

From: SAMUMED, LLC

To: BIOSPLICE THERAPEUTICS, INC.

Reel/Frame 055693/0882 →

Assignment of Assignor's Interest Jul 21, 2021

From: SAMUMED, LLC

To: BIOSPLICE THERAPEUTICS, INC.

Reel/Frame 056928/0695 →

Assignment of Assignor's Interest Jul 21, 2021

From: HOOD, JOHN; DESHMUKH, VISHAL; O'GREEN, ALYSSA-LAUREN; BOSSARD, CARINE

To: SAMUMED, LLC

Reel/Frame 056928/0435 →